Burning Rock Biotech (BNR) Current Assets (2019 - 2025)

Burning Rock Biotech's Current Assets history runs 7 years deep, the most recent figure standing at $104.1 million for Q4 2025.

• In Q4 2025, Current Assets fell 3.68% year-over-year to $104.1 million; the TTM figure through Dec 2025 stood at $104.1 million (down 3.68% YoY), while the FY2025 annual figure was $105.6 million, down 0.73% from the prior year.
• Current Assets was $104.1 million for Q4 2025 at Burning Rock Biotech, roughly flat from $103.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $367.9 million in Q1 2021 to a low of $103.4 million in Q2 2025.
• Historically, Current Assets has averaged $179.6 million across 5 years, with a median of $141.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Assets sank 38.44% in 2022, then dropped 3.68% in 2025.
• A 5-year view of Current Assets shows it stood at $284.8 million in 2021, then slumped by 37.86% to $177.0 million in 2022, then tumbled by 30.62% to $122.8 million in 2023, then declined by 11.95% to $108.1 million in 2024, then retreated by 3.68% to $104.1 million in 2025.
• The last three Current Assets figures came in at $104.1 million (Q4 2025), $103.9 million (Q3 2025), and $103.4 million (Q2 2025), per Business Quant data.